STAT
@statnews
Reporting from the frontiers of health & medicine.
Sign up for any of our newsletters here:
Joined July 2015
4.7K Following 165.5K Followers
In a large diabetes study, Eli Lilly's investigational drug retatrutide was more effective at lowering blood sugar and cutting weight than Novo Nordisk’s Ozempic.
However, questions remain about long-term safety. More details here:
Show more
